Clinical Trials Browser

Has results × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × ibrutinib × Clear all

NCT03267186 2023-08-01

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma